RANKL Blocking Peptide
£103.13
RANKL Blocking Peptide (R1243-50ug)
Product
| Cat # R1243-50ug | Size 50 µg |
Price
£103.13
|
Qty
|
Description
RANKL (Receptor Activator for Nuclear Factor κ B Ligand), also known as TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and ODF (osteoclast differentiation factor), is a member of the tumor necrosis factor family cytokine.1 RANKL is essential for osteoclast formation, activation, and survival.2 RANKL through interaction with its receptor RANK can modulate matrix degradation and inflammation.3 RANKL and RANK have essential roles in lymph node formation, establishment of the thymic microenvironment, and development of a lactating mammary gland during pregnancy. Consequently, novel drugs specifically targeting RANK, RANKL, and their signaling pathways in osteoclasts are expected to revolutionize the treatment of various ailments associated with bone loss, such as arthritis, periodontal disease, cancer metastases, and osteoporosis.4
Specifications
| Manufacturer Cat# | R1243 |
|---|---|
| Product Size | 50 µg |
| Concentration | 0.2 mg/ml |
| Formulation | This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. |
| Alternate Names | Blocking Peptide sRANKL CD254 TRANCE hRANKL2 sOdf TNF-Related Activation-Induced Cytokine [TRANCE] Osteoprotegrin Ligand [OPGL] Osteoclast Differentiation Factor [ODF] TNFSF11 Human RANKL RANKL Blocking Peptide |
| Target | sRANKL |
| Storage | Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. |
| Protein | sRANKL |